Emicizumab-kxwh Subcutaneous and Insulin Degludec (U-100) Vials
Determining the interaction of Emicizumab-kxwh Subcutaneous and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Insulin Degludec (U-200) Prefilled Pens
- Emicizumab-kxwh Subcutaneous-Insulin degludec and liraglutide
- Emicizumab-kxwh Subcutaneous-Insulin degludec and liraglutide Subcutaneous
- Emicizumab-kxwh Subcutaneous-Insulin degludec Subcutaneous
- Emicizumab-kxwh Subcutaneous-Insulin detemir
- Emicizumab-kxwh Subcutaneous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Emla
- Insulin Degludec (U-100) Vials-Emla Topical
- Insulin Degludec (U-100) Vials-Emo-Cort Scalp Solution Topical application
- Insulin Degludec (U-100) Vials-Emo-Cort Topical application
- Insulin Degludec (U-100) Vials-Emoquette
- Insulin Degludec (U-100) Vials-Empagliflozin